Exenatide Once-weekly as a Treatment for Multiple System Atrophy
NCT04431713
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Multiple System Atrophy
Interventions
DRUG:
Exenatide Pen Injector [Bydureon]
Sponsor
University College, London